Fundraising FoxUlu Ventures — 2017 Investments
4 investments dated 2017 · listed companies and verified rows first · show all
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+18 more
Sail Internet is a fiber-based internet service provider serving the San Francisco Bay Area and Silicon Valley since 2015.
Fremont, US
Kevin Fisher(Chief Product Officer)inGeorge GinisinDana Wayne Tom(Executive Officer, Director)
BoardAshmeet Sidana(Director)in
Board seatClint Korver· per SEC Form D
Co-investorsAlumni VenturesBetter Ventures Central LlcBrainstorm VenturesLong Venture PartnersStartXV1 VC+1 more
.png)
Medrio provides a no-code electronic data capture (EDC) platform for clinical trials, aimed at small and scaling life sciences sponsors and CRO teams.
BiotechDigital HealthSaaSSan Francisco, US
Michael Novotny(Executive Officer, Director)
BoardRyan Drant(Director)inBradley Sloan(Director)inRichard Scheller(Director)Doug Engfer(Director)Dave Lipscomb(Director)
Co-investorsMontage CapitalQuesta CapitalThink+ Ventures Management, LlcTSVC
Rubik was a New York-based proptech startup using data science and machine learning to source off-market single-family rental homes for institutional investors.
Newark, US
Amar Sehic(Mr. Sehic is President, CEO and a Director of the Company.)Tommaso Montagni(Executive Officer, Director)
BoardKrenar Roka(Mr. Roka is a Director of the Company.)
Co-investorsAAF Management Ltd.GaingelsGreen Egg VenturesRemarkable VenturesSouth Central VenturesEntrepreneurs Roundtable Accelerator (ERA)
__Twitter.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.